
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.670 | 0.670 | 0.000 |
Shares | 98.700 | 98.700 | 0.000 |
Other | 0.630 | 0.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.611 | 14.890 |
Price to Book | 2.226 | 2.066 |
Price to Sales | 1.777 | 1.474 |
Price to Cash Flow | 10.712 | 9.344 |
Dividend Yield | 3.363 | 3.342 |
5 Years Earnings Growth | 8.306 | 9.012 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 21.740 | 20.328 |
Industrials | 19.980 | 17.345 |
Healthcare | 13.140 | 13.486 |
Consumer Defensive | 9.620 | 10.764 |
Technology | 7.800 | 9.312 |
Consumer Cyclical | 7.210 | 9.118 |
Basic Materials | 5.940 | 6.167 |
Communication Services | 4.670 | 5.648 |
Utilities | 4.610 | 4.728 |
Energy | 4.400 | 4.253 |
Real Estate | 0.880 | 1.689 |
Number of long holdings: 237
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 2.60 | 250.100 | -1.83% | |
ASML Holding | NL0010273215 | 2.56 | 616.90 | +1.02% | |
Novartis | CH0012005267 | 2.15 | 94.06 | +1.09% | |
Novo Nordisk B | DK0062498333 | 2.05 | 323.1 | +4.60% | |
Nestle | CH0038863350 | 1.97 | 72.10 | +0.04% | |
Roche Holding Participation | CH0012032048 | 1.89 | 246.40 | -1.08% | |
AstraZeneca | GB0009895292 | 1.63 | 10,922.0 | -0.26% | |
Shell | GB00BP6MXD84 | 1.60 | 30.85 | +0.19% | |
HSBC | GB0005405286 | 1.51 | 939.30 | +0.55% | |
Siemens AG | DE0007236101 | 1.47 | 232.40 | +2.33% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0058496679 | 2.58B | -3.15 | 10.86 | 9.67 | ||
LU0553726919 | 492.23M | 7.86 | -1.59 | 0.22 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review